241 related articles for article (PubMed ID: 19094071)
1. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
4. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
[TBL] [Abstract][Full Text] [Related]
5. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
Talbott EO; Zborowski JV; Boudreaux MY; McHugh-Pemu KP; Sutton-Tyrrell K; Guzick DS
J Clin Endocrinol Metab; 2004 Dec; 89(12):6061-7. PubMed ID: 15579759
[TBL] [Abstract][Full Text] [Related]
6. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
7. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
Zueff LF; Martins WP; Vieira CS; Ferriani RA
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
[TBL] [Abstract][Full Text] [Related]
9. Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.
Ketel IJ; Stehouwer CD; Henry RM; Serné EH; Hompes P; Homburg R; Smulders YM; Lambalk CB
J Clin Endocrinol Metab; 2010 Oct; 95(10):4566-75. PubMed ID: 20660051
[TBL] [Abstract][Full Text] [Related]
10. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
Kaya C; Pabuccu R; Berker B; Satiroglu H
Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
[TBL] [Abstract][Full Text] [Related]
11. Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA
Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540
[TBL] [Abstract][Full Text] [Related]
12. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
14. Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
Alexandraki K; Protogerou AD; Papaioannou TG; Piperi C; Mastorakos G; Lekakis J; Panidis D; Diamanti-Kandarakis E
Hormones (Athens); 2006; 5(2):126-36. PubMed ID: 16807225
[TBL] [Abstract][Full Text] [Related]
15. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
[TBL] [Abstract][Full Text] [Related]
17. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
